|
TW200940547A
|
|
Organic compounds
|
|
TW200932241A
|
|
Organic compounds
|
|
TW200922596A
|
|
4,4-disubstituted piperidines
|
|
TW200927101A
|
|
Trisubstituted piperidines
|
|
EP2018862A1
|
|
Substituted piperidines as therapeutic compounds
|
|
WO2008119744A1
|
|
Heterocyclic spiro-compounds
|
|
WO2008113835A1
|
|
Process for preparing (r or s)-5-{1-azido-3-[6-methoxy-5-(3-methoxy-propoxy)-pyridin-3-ylmethyl]-4-methyl-pentyl}-3-alkyl-dihydro-furan-2-one
|
|
EP1958634A2
|
|
Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease
|
|
EP1987834A2
|
|
Substituted piperidines as therapeutic compounds
|
|
EP1958666A1
|
|
Heterocyclic-substituted alkanamides as therapeutic compounds
|
|
TW200837046A
|
|
Process for preparing organic compounds
|
|
EP1908763A1
|
|
Bicyclic compounds
|
|
EP1908762A2
|
|
Organic compounds
|
|
EP1908471A1
|
|
Tetrahydropyridines as renin inhibitors
|
|
TW200831463A
|
|
Nitrate esters of aminoalcohols
|
|
TW200821303A
|
|
Organic compounds
|
|
EP1867329A2
|
|
5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
|
|
EP1872780A2
|
|
Omega-Phenyloctanamides as therapeutic compounds
|
|
BRPI0712430A2
|
|
2,5-di-substituted piperidines.
|
|
TW200808812A
|
|
Imidazo compounds
|
